Interleukin 10 gene promoter polymorphism –819 T/C modulates IL-10 levels independently of PGE2 in multibacillary leprosy
Nursing and Health Sciences Journal (NHSJ) · 01.06.2026 · 6 (2) · 314
DOI: 10.53713/nhsj.v6i2.684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nursing and Health Sciences Journal (NHSJ), online erschienen am 01.06.2026. Verfasst von Fitriyanti und 6 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
The IL-10 –819 T/C promoter polymorphism influences cytokine production in leprosy, yet its functional interplay with serum IL-10 and prostaglandin E2 (PGE2) in Indonesian populations remains undefined. This study investigated its association with multibacillary (MB) leprosy susceptibility and systemic mediator levels. In a case–control design, 35 MB patients and 35 healthy controls from Banyuasin Regency, South Sumatra, were enrolled. PCR-RFLP was used for genotyping, and ELISA was used to quantify serum IL-10 and PGE2. Genotype and allele frequencies did not differ between groups (OR = 1.121; 95% CI: 0.439–2.863; p = 0.811), indicating no susceptibility effect. Serum IL-10 was significantly elevated in patients (median 2.15 pg/mL) versus controls (1.23 pg/mL; p = 0.033). Within cases, IL-10 exhibited a C-allele dose-dependent gradient (TT: 3.82; CT: 4.96; CC: 16.20 pg/mL), though statistically underpowered (H = 0.452; p = 0.798). PGE2 showed no intergroup differences (p = 0.142), nor correlations with genotype (p = 0.915) or IL-10 (rₛ = −0.057; p = 0.639). The IL-10 –819 T/C variant does not predict MB susceptibility but, in a pathogen-context-dependent manner, functionally amplifies IL-10 production. This genetic effect operates independently of systemic PGE2 regulation, highlighting distinct immunomodulatory pathways and supporting the CC genotype as a potential biomarker of immune-suppression severity.
Zitieren
APA
Fitriyanti, Lipinwati, Istarini, A., Ekaputri, T. W., Nastiti, N. I., Adnyana, I. M. D. M., & Pratiwi, R. (2026). Interleukin 10 gene promoter polymorphism –819 T/C modulates IL-10 levels independently of PGE2 in multibacillary leprosy. Nursing and Health Sciences Journal (NHSJ), 6(2), 314. https://doi.org/10.53713/nhsj.v6i2.684
Vancouver
Fitriyanti, Lipinwati, Istarini A, Ekaputri TW, Nastiti NI, Adnyana IMDM, et al. Interleukin 10 gene promoter polymorphism –819 T/C modulates IL-10 levels independently of PGE2 in multibacillary leprosy. Nursing and Health Sciences Journal (NHSJ). 2026;6(2):314. doi:10.53713/nhsj.v6i2.684
BibTeX
@article{Fitriyanti2026,
author = {Fitriyanti and Lipinwati and Istarini, Attiya and Ekaputri, Tia Wida and Nastiti, Niken Irfa and Adnyana, I Made Dwi Mertha and Pratiwi, Rini},
title = {Interleukin 10 gene promoter polymorphism –819 T/C modulates IL-10 levels independently of PGE2 in multibacillary leprosy},
journal = {Nursing and Health Sciences Journal (NHSJ)},
year = {2026},
volume = {6},
number = {2},
pages = {314},
doi = {10.53713/nhsj.v6i2.684}
}
EUVIMED